Mueller RB, Schulze-Koops H, Furst DE, Cohen SB, et al. Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel). Clin Rheumatol 2022 Jan 1. pii: 10.1007/s10067-021-05908.
PMID: 34973077